SAMAD SAM
SEC CIK 1694295 · EDGAR
Most active insiders at DGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Davis J. E. | CEO, Pres, Dir | — | $17.08M |
| 2 | Doherty Catherine T. | EVP, Regional Businesses | — | $6.96M |
| 3 | PREVOZNIK MICHAEL E | SVP, GC | — | $6.69M |
| 4 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | — | $2.17M |
| 5 | Plewman Patrick | SVP for Diagnostic Services | — | $2.03M |
| 6 | DELANEY MARK E | SVP, Chief Commercial Off | — | $1.86M |
| 7 | PFEIFFER GARY M | Dir | — | $270.3K |
| 8 | Gregg Vicky B | Dir | — | $239.7K |
| 9 | Lassiter Wright III | Dir | — | — |
| 10 | Deppe Michael J | SVP, CAO, Corp. Ctrl | — | — |
| 12 | SAMAD SAM | EVP, CFO | — | — |
Transactions 31
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-27 16:33 | 2026-07-22 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | A - Grant | $206.81 | +102 | 33.5K | +0.3% | +$21.1K | |
| 2026-04-24 18:24 | 2026-04-20 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | A - Grant | $194.70 | +108 | 33.4K | +0.3% | +$21.0K | |
| 2026-03-06 | 2026-03-04 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | A - Grant | $204.86 | +13.9K | 41.0K | +52% | +$2.86M | |
| 2026-03-06 | 2026-03-04 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | F - Tax | $204.86 | -7,720 | 33.3K | -19% | -$1.58M | |
| 2026-03-04 | 2026-03-02 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | F - Tax | $204.86 | -869 | 27.0K | -3% | -$178.0K | |
| DM | 2026-02-20 | 2026-02-18 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | F - Tax | $208.37 | -1,865 | 28.9K | -6% | -$388.6K |
| DM | 2026-02-20 | 2026-01-28+ | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | A - Grant | $3.14 | +4,034 | 27.9K | +17% | +$12.7K |
| 2025-10-24 | 2025-10-21 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | A - Grant | $189.08 | +68 | 25.7K | +0.3% | +$12.9K | |
| 2025-07-25 | 2025-07-21 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | L - Small Acq | $167.50 | +72 | 25.7K | +0.3% | +$12.1K | |
| 2025-07-17 | 2025-07-16 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | F - Tax | $169.01 | -850 | 25.6K | -3% | -$143.7K | |
| 2025-05-02 | 2025-04-21 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | L - Small Acq | $164.42 | +74 | 26.5K | +0.3% | +$12.2K | |
| 2025-03-05 | 2025-03-04 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | F - Tax | $173.74 | -7,684 | 26.4K | -23% | -$1.34M | |
| 2025-03-05 | 2025-03-04 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | A - Grant | $173.74 | +13.9K | 34.1K | +69% | +$2.41M | |
| 2025-02-28 | 2025-02-26 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | F - Tax | $171.75 | -869 | 20.2K | -4% | -$149.3K | |
| 2025-02-21 | 2025-02-19 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | F - Tax | $169.71 | -1,031 | 21.0K | -5% | -$175.0K | |
| D | 2025-02-14 | 2025-02-12 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | A - Grant | $0.00 | +4,538 | 22.1K | +26% | $0 |
| 2025-01-31 | 2025-01-29 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | L - Small Acq | $158.04 | +35 | 17.5K | +0.2% | +$5,531 | |
| 2024-10-25 | 2024-10-21 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | L - Small Acq | $149.37 | +37 | 17.5K | +0.2% | +$5,527 | |
| 2024-07-26 | 2024-07-22 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | L - Small Acq | $146.97 | +21 | 17.5K | +0.1% | +$3,086 | |
| 2024-07-18 | 2024-07-16 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | F - Tax | $142.65 | -3,910 | 17.4K | -18% | -$557.8K | |
| 2024-04-26 | 2024-04-22 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | A - Grant | $126.25 | +24 | 21.4K | +0.1% | +$3,030 | |
| 2024-03-01 | 2024-02-28 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | F - Tax | $126.36 | -656 | 21.3K | -3% | -$82.9K | |
| D | 2024-02-16 | 2024-02-14 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | A - Grant | $0.00 | +5,478 | 22.0K | +33% | $0 |
| 2024-02-02 | 2024-01-31 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | A - Grant | $129.33 | +17 | 16.5K | +0.1% | +$2,199 | |
| 2023-10-26 | 2023-10-23 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | A - Grant | $122.86 | +18 | 16.5K | +0.1% | +$2,211 | |
| 2023-07-17 | 2023-07-14 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | F - Tax | $140.18 | -3,909 | 16.5K | -19% | -$548.0K | |
| D | 2023-02-27 | 2023-02-23 | DGX | Quest Diagnostics | SAMAD SAM | EVP, CFO | A - Grant | $0.00 | +4,710 | 20.4K | +30% | $0 |
| D | 2022-03-03 | 2022-03-01 | ILMN | ILLUMINA, INC. | SAMAD SAM | SVP, CFO | A - Grant | $0.00 | +2,082 | 11.3K | +23% | $0 |
| D | 2022-02-24 | 2022-02-22 | ILMN | ILLUMINA, INC. | SAMAD SAM | SVP, CFO | M - OptEx | $0.00 | +4,561 | 11.0K | +71% | $0 |
| D | 2022-02-24 | 2022-02-22 | ILMN | ILLUMINA, INC. | SAMAD SAM | SVP, CFO | F - Tax | $319.86 | -1,808 | 9,215 | -16% | -$578.3K |
| 2021-11-09 | 2021-11-05 | ILMN | ILLUMINA, INC. | SAMAD SAM | SVP, CFO | F - Tax | $408.14 | -723 | 6,462 | -10% | -$295.1K |
Purchase Sale Sale after option exercise All abbreviations